Q1 2024 Holdings
Filed 2024-05-15 | 208 holdings | $6.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Becton Dickinson & Co(BDX) | COM | 075887109 | $102.9M | 415,700 | 1.6% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $105.4M | 1,103,136 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $117.1M | 4,006,000 | 1.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $117.4M | 2,796,615 | 1.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $122.7M | 2,153,388 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $137.2M | 918,284 | 2.1% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $146.7M | 9,965,862 | 2.2% |
| Stryker Corporation(SYK) | COM | 863667101 | $160.8M | 449,340 | 2.5% |
| Abbott Labs(ABT) | COM | 002824100 | $163.0M | 1,434,183 | 2.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $163.5M | 5,073,600 | 2.5% |
| Dexcom Inc(DXCM) | COM | 252131107 | $169.4M | 1,221,197 | 2.6% |
| Moderna Inc(MRNA) | COM | 60770K107 | $182.3M | 1,711,089 | 2.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $195.1M | 2,819,482 | 3.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $215.7M | 3,148,676 | 3.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $272.3M | 682,186 | 4.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $279.5M | 668,750 | 4.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $283.5M | 2,055,874 | 4.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $319.3M | 811,016 | 4.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $359.8M | 8,299,514 | 5.5% |